1 |
Chipangura JK, Ntamo Y, Mohr B, Chellan N. A review of challenges and prospects of 3D cell-based culture models used for studying drug induced liver injury during early phases of drug development. Hum Exp Toxicol 2023;42:9603271221147884. [PMID: 36879529 DOI: 10.1177/09603271221147884] [Reference Citation Analysis]
|
2 |
Gökçe F, Kaestli A, Lohasz C, de Geus M, Kaltenbach HM, Renggli K, Bornhauser B, Hierlemann A, Modena M. Microphysiological Drug-Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia. Adv Healthc Mater 2023;12:e2202506. [PMID: 36651229 DOI: 10.1002/adhm.202202506] [Reference Citation Analysis]
|
3 |
Rajput P, Krishnamurthy S. Standardization and validation of novel ex-vivo method for mitochondrial bioenergetics using mitochondrial modulators. J Pharmacol Toxicol Methods 2023;119:107209. [PMID: 36007863 DOI: 10.1016/j.vascn.2022.107209] [Reference Citation Analysis]
|
4 |
Inui J, Ueyama-toba Y, Mitani S, Mizuguchi H. Development of a method of passaging and freezing human iPS cell-derived hepatocytes to improve their functions and application.. [DOI: 10.21203/rs.3.rs-2118517/v1] [Reference Citation Analysis]
|
5 |
Ahmed T. Organ-on-a-chip microengineering for bio-mimicking disease models and revolutionizing drug discovery. Biosensors and Bioelectronics: X 2022;11:100194. [DOI: 10.1016/j.biosx.2022.100194] [Reference Citation Analysis]
|
6 |
Kulsharova G, Kurmangaliyeva A, Darbayeva E, Rojas-Solórzano L, Toxeitova G. Development of a Hybrid Polymer-Based Microfluidic Platform for Culturing Hepatocytes towards Liver-on-a-Chip Applications. Polymers (Basel) 2021;13:3215. [PMID: 34641031 DOI: 10.3390/polym13193215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|